Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

Market Cap	8.95B +1.6%
Revenue (ttm)	5.20B +3.3%
Net Income	207.76M +38.9%
EPS	0.27 +35.0%
Shares Out	760.85M
PE Ratio	43.55
Forward PE	24.42
Dividend	0.11 (0.93%)
Ex-Dividend Date	Jun 1, 2026

Volume	7,590,148
Open	12.32
Previous Close	11.87
Day's Range	11.52 - 12.32
52-Week Range	11.48 - 20.37
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1993
• Employees: 5,479
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300171

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.